

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.94277902 |
| 2 | axon extension involved in axon guidance (GO:0048846) | 4.94277902 |
| 3 | epithelial cell fate commitment (GO:0072148) | 4.69972858 |
| 4 | regulation of synapse maturation (GO:0090128) | 3.72215709 |
| 5 | response to pheromone (GO:0019236) | 3.66437852 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.64497947 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 3.63064122 |
| 8 | response to muramyl dipeptide (GO:0032495) | 3.60453999 |
| 9 | establishment of protein localization to Golgi (GO:0072600) | 3.54604724 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53675424 |
| 11 | chondrocyte proliferation (GO:0035988) | 3.51721550 |
| 12 | locomotory exploration behavior (GO:0035641) | 3.45375156 |
| 13 | synaptic vesicle maturation (GO:0016188) | 3.42342358 |
| 14 | neural tube formation (GO:0001841) | 3.38774866 |
| 15 | cellular response to ethanol (GO:0071361) | 3.36937375 |
| 16 | lung epithelium development (GO:0060428) | 3.35674683 |
| 17 | L-amino acid import (GO:0043092) | 3.34716998 |
| 18 | positive regulation of synapse maturation (GO:0090129) | 3.34094418 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.29855180 |
| 20 | regulation of beta-amyloid formation (GO:1902003) | 3.27160271 |
| 21 | protein targeting to Golgi (GO:0000042) | 3.25992307 |
| 22 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.21184932 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.18568914 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15396929 |
| 25 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.14722971 |
| 26 | lens fiber cell development (GO:0070307) | 3.11909284 |
| 27 | microglial cell activation (GO:0001774) | 3.10119367 |
| 28 | positive regulation of fibroblast migration (GO:0010763) | 3.09945744 |
| 29 | regulation of sarcomere organization (GO:0060297) | 3.04996772 |
| 30 | regulation of relaxation of muscle (GO:1901077) | 3.00965701 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00665312 |
| 32 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00390818 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93966435 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93966435 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93966435 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 2.93966435 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93966435 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 2.93966435 |
| 39 | hepatocyte apoptotic process (GO:0097284) | 2.92610816 |
| 40 | Notch signaling involved in heart development (GO:0061314) | 2.88324332 |
| 41 | synaptic vesicle endocytosis (GO:0048488) | 2.85704536 |
| 42 | glycine transport (GO:0015816) | 2.85442777 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84651245 |
| 44 | negative regulation of cell killing (GO:0031342) | 2.84651245 |
| 45 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.82799215 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.82785950 |
| 47 | activated T cell proliferation (GO:0050798) | 2.82344814 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 2.82014432 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81416834 |
| 50 | response to host (GO:0075136) | 2.81416834 |
| 51 | response to host defenses (GO:0052200) | 2.81416834 |
| 52 | interkinetic nuclear migration (GO:0022027) | 2.80852398 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80615598 |
| 54 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.79887694 |
| 55 | cell communication by electrical coupling (GO:0010644) | 2.79434476 |
| 56 | cellular extravasation (GO:0045123) | 2.78990495 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.78418947 |
| 58 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.76311712 |
| 59 | amino acid import (GO:0043090) | 2.75820027 |
| 60 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.75529333 |
| 61 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.74305493 |
| 62 | negative regulation of neurotransmitter transport (GO:0051589) | 2.73786304 |
| 63 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.73395695 |
| 64 | nucleus localization (GO:0051647) | 2.73270395 |
| 65 | protein K11-linked deubiquitination (GO:0035871) | 2.72517580 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 2.71696147 |
| 67 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.71276241 |
| 68 | macroautophagy (GO:0016236) | 2.70757315 |
| 69 | glutamate secretion (GO:0014047) | 2.68299481 |
| 70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.67085442 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66635386 |
| 72 | regulation of memory T cell differentiation (GO:0043380) | 2.66336033 |
| 73 | early endosome to late endosome transport (GO:0045022) | 2.66044689 |
| 74 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.65398510 |
| 75 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65277221 |
| 76 | neutrophil mediated immunity (GO:0002446) | 2.64759880 |
| 77 | regulation of establishment of cell polarity (GO:2000114) | 2.63323061 |
| 78 | regulation of protein glycosylation (GO:0060049) | 2.62669381 |
| 79 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.60713169 |
| 80 | cardiac left ventricle morphogenesis (GO:0003214) | 2.57960185 |
| 81 | histone H3-K4 trimethylation (GO:0080182) | 2.57500967 |
| 82 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.57298563 |
| 83 | venous blood vessel morphogenesis (GO:0048845) | 2.57137410 |
| 84 | macrophage activation (GO:0042116) | 2.56819040 |
| 85 | type B pancreatic cell development (GO:0003323) | 2.56383059 |
| 86 | exocrine pancreas development (GO:0031017) | 2.56352166 |
| 87 | inner ear receptor cell differentiation (GO:0060113) | 2.56294608 |
| 88 | positive regulation of myoblast differentiation (GO:0045663) | 2.55844374 |
| 89 | central nervous system neuron axonogenesis (GO:0021955) | 2.55560523 |
| 90 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.53526507 |
| 91 | Golgi to endosome transport (GO:0006895) | 2.53515276 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.53110867 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.53071948 |
| 94 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.51732956 |
| 95 | regulation of synaptic vesicle transport (GO:1902803) | 2.49598369 |
| 96 | axon ensheathment in central nervous system (GO:0032291) | 2.49317899 |
| 97 | central nervous system myelination (GO:0022010) | 2.49317899 |
| 98 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49263127 |
| 99 | vesicle transport along microtubule (GO:0047496) | 2.48905326 |
| 100 | positive regulation of muscle hypertrophy (GO:0014742) | 2.46641286 |
| 101 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.46641286 |
| 102 | synaptic transmission, glutamatergic (GO:0035249) | 2.45698270 |
| 103 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.44002730 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.43224146 |
| 105 | protein K48-linked deubiquitination (GO:0071108) | 2.43162385 |
| 106 | regulation of ARF protein signal transduction (GO:0032012) | 2.43011795 |
| 107 | proline transport (GO:0015824) | 2.42463511 |
| 108 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.41288261 |
| 109 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.40929905 |
| 110 | axon extension (GO:0048675) | 2.39923754 |
| 111 | prenylation (GO:0097354) | 2.38132868 |
| 112 | protein prenylation (GO:0018342) | 2.38132868 |
| 113 | myeloid leukocyte mediated immunity (GO:0002444) | 2.36980393 |
| 114 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.36824453 |
| 115 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.36369371 |
| 116 | lens morphogenesis in camera-type eye (GO:0002089) | 2.36217151 |
| 117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.35185057 |
| 118 | protein targeting to lysosome (GO:0006622) | 2.34286070 |
| 119 | establishment of protein localization to vacuole (GO:0072666) | 2.34286070 |
| 120 | protein targeting to vacuole (GO:0006623) | 2.34286070 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.33838288 |
| 122 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.33838288 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33739468 |
| 124 | response to epinephrine (GO:0071871) | 2.33705731 |
| 125 | iron ion import (GO:0097286) | 2.33417512 |
| 126 | lipid translocation (GO:0034204) | 2.32900162 |
| 127 | phospholipid translocation (GO:0045332) | 2.32900162 |
| 128 | clathrin coat assembly (GO:0048268) | 2.31977137 |
| 129 | coronary vasculature morphogenesis (GO:0060977) | 2.31415574 |
| 130 | myofibril assembly (GO:0030239) | 2.31372554 |
| 131 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.31359763 |
| 132 | import into cell (GO:0098657) | 2.30992667 |
| 133 | B cell receptor signaling pathway (GO:0050853) | 2.29116894 |
| 134 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.28659662 |
| 135 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.28481638 |
| 136 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.28456139 |
| 137 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.28271666 |
| 138 | collecting duct development (GO:0072044) | 2.28222657 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.28158009 |
| 140 | detection of external biotic stimulus (GO:0098581) | 2.27738447 |
| 141 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.27488069 |
| 142 | neuron projection extension (GO:1990138) | 2.27182666 |
| 143 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.27114280 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.26113079 |
| 145 | presynaptic membrane assembly (GO:0097105) | 2.25696866 |
| 146 | negative regulation of B cell mediated immunity (GO:0002713) | 2.24845558 |
| 147 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.24845558 |
| 148 | regulation of platelet aggregation (GO:0090330) | 2.24814169 |
| 149 | peptidyl-lysine trimethylation (GO:0018023) | 2.24653655 |
| 150 | anatomical structure maturation (GO:0071695) | 2.24568071 |
| 151 | histone mRNA catabolic process (GO:0071044) | 2.24552292 |
| 152 | dendrite morphogenesis (GO:0048813) | 2.24534123 |
| 153 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.21514752 |
| 154 | nerve growth factor signaling pathway (GO:0038180) | 2.21058253 |
| 155 | neutrophil activation (GO:0042119) | 2.20042422 |
| 156 | phospholipid homeostasis (GO:0055091) | 2.19866088 |
| 157 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.19784836 |
| 158 | protein localization to Golgi apparatus (GO:0034067) | 2.18840661 |
| 159 | detection of calcium ion (GO:0005513) | 2.18620192 |
| 160 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.18556018 |
| 161 | response to host immune response (GO:0052572) | 2.18556018 |
| 162 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.18454218 |
| 163 | mechanoreceptor differentiation (GO:0042490) | 2.18432800 |
| 164 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.17949970 |
| 165 | cochlea development (GO:0090102) | 2.17524676 |
| 166 | protein localization to synapse (GO:0035418) | 2.16767178 |
| 167 | cellular potassium ion homeostasis (GO:0030007) | 2.16249976 |
| 168 | stress granule assembly (GO:0034063) | 2.14736348 |
| 169 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.14689207 |
| 170 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.14665740 |
| 171 | vocalization behavior (GO:0071625) | 2.14245347 |
| 172 | activation of protein kinase A activity (GO:0034199) | 2.14074623 |
| 173 | heart valve formation (GO:0003188) | 2.14052508 |
| 174 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.13836813 |
| 175 | establishment of nucleus localization (GO:0040023) | 2.13474192 |
| 176 | response to parathyroid hormone (GO:0071107) | 2.12856672 |
| 177 | I-kappaB phosphorylation (GO:0007252) | 2.12239743 |
| 178 | macrophage activation involved in immune response (GO:0002281) | 2.11560997 |
| 179 | myelin assembly (GO:0032288) | 2.11409000 |
| 180 | glutamate receptor signaling pathway (GO:0007215) | 2.08772359 |
| 181 | lipoprotein transport (GO:0042953) | 2.08619886 |
| 182 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.07219348 |
| 183 | sodium ion export (GO:0071436) | 2.06612876 |
| 184 | cardiac ventricle formation (GO:0003211) | 2.06545313 |
| 185 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.06427911 |
| 186 | neuronal stem cell maintenance (GO:0097150) | 2.04770786 |
| 187 | negative regulation of myoblast differentiation (GO:0045662) | 2.04430683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.22226806 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.13098564 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.82517866 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.71095646 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.66901821 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33406433 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29323740 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.25789255 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24427517 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22813172 |
| 11 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.10095644 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01524244 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00379166 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91725778 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87885141 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87885141 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82581316 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81820463 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81219935 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.77421300 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.77229836 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73563904 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68157943 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66998437 |
| 25 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65737802 |
| 26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65634604 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65433046 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63084256 |
| 29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60712985 |
| 30 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59882178 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59808559 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59449374 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58867316 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58150094 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57459307 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56564600 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56084206 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54710346 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54179049 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52504043 |
| 41 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52450852 |
| 42 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.51799738 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50458859 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49112130 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48661346 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48415844 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48371476 |
| 48 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47091323 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46633410 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46093443 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45527758 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45480873 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44573837 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43830094 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43823689 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43321917 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43017201 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41490898 |
| 59 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41294670 |
| 60 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41294670 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41105414 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40172267 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36397981 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36095105 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35404148 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34773367 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33789416 |
| 68 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33278159 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32730782 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32275052 |
| 71 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32233327 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31544054 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30483329 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29489028 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28665740 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28651488 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.27794403 |
| 78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25176175 |
| 79 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24546622 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24494188 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24152678 |
| 82 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.23859031 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23511757 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23362209 |
| 85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23198571 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23087108 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23087108 |
| 88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23086172 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22539748 |
| 90 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22469644 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22106918 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.21173157 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21046026 |
| 94 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19880027 |
| 95 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19645877 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19326550 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19326550 |
| 98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18865678 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 1.18731603 |
| 100 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17927533 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17230686 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 1.16956878 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16476896 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16234085 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16149821 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15565653 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15290770 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15058687 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14741727 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14417739 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13680289 |
| 112 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13460679 |
| 113 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12978049 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12579814 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12293004 |
| 116 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11481744 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10278539 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09947425 |
| 119 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09471185 |
| 120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08935186 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08522186 |
| 122 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08510641 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08359637 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07665089 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07033551 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06758201 |
| 127 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06336596 |
| 128 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05927416 |
| 129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05921083 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05684137 |
| 131 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05483884 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05124115 |
| 133 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04704463 |
| 134 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04272866 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02852293 |
| 136 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02012470 |
| 137 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01909537 |
| 138 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01391527 |
| 139 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01139095 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01096299 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00117827 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99602779 |
| 143 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99525522 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98593937 |
| 145 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98567324 |
| 146 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98494850 |
| 147 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96891839 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96766979 |
| 149 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.96765578 |
| 150 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96018538 |
| 151 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95819048 |
| 152 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95296854 |
| 153 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91760629 |
| 154 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89478833 |
| 155 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89459736 |
| 156 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89037052 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87759256 |
| 158 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85997764 |
| 159 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84587384 |
| 160 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84427452 |
| 161 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83749240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.41343459 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 6.21613744 |
| 3 | MP0003880_abnormal_central_pattern | 4.28726449 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.75230088 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.69217322 |
| 6 | MP0000566_synostosis | 3.57908779 |
| 7 | MP0003724_increased_susceptibility_to | 3.30652162 |
| 8 | MP0005257_abnormal_intraocular_pressure | 3.17830984 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.07069473 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.99341062 |
| 11 | MP0001958_emphysema | 2.56073503 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.46170942 |
| 13 | MP0002009_preneoplasia | 2.05155305 |
| 14 | MP0004510_myositis | 1.99520103 |
| 15 | MP0004036_abnormal_muscle_relaxation | 1.89804991 |
| 16 | MP0000015_abnormal_ear_pigmentation | 1.87163053 |
| 17 | MP0000427_abnormal_hair_cycle | 1.86524057 |
| 18 | MP0003787_abnormal_imprinting | 1.81084727 |
| 19 | MP0003283_abnormal_digestive_organ | 1.80799384 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.80610496 |
| 21 | MP0003646_muscle_fatigue | 1.78843793 |
| 22 | MP0000371_diluted_coat_color | 1.76111379 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.70142723 |
| 24 | MP0006054_spinal_hemorrhage | 1.70053867 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.68801168 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.67342318 |
| 27 | MP0003828_pulmonary_edema | 1.65997276 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.64276465 |
| 29 | MP0004858_abnormal_nervous_system | 1.60610618 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.60183916 |
| 31 | MP0002102_abnormal_ear_morphology | 1.59724911 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.57618549 |
| 33 | MP0000749_muscle_degeneration | 1.55762731 |
| 34 | MP0008057_abnormal_DNA_replication | 1.53427178 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.48365138 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.46694463 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.44530798 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.43213046 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.42330589 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.39810370 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.38940628 |
| 42 | MP0001299_abnormal_eye_distance/ | 1.38085885 |
| 43 | MP0008260_abnormal_autophagy | 1.31019087 |
| 44 | MP0002168_other_aberrant_phenotype | 1.30116265 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.28683437 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.28582225 |
| 47 | MP0002064_seizures | 1.27200638 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.25900477 |
| 49 | MP0008569_lethality_at_weaning | 1.22536055 |
| 50 | MP0009745_abnormal_behavioral_response | 1.22326560 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.22204154 |
| 52 | MP0002736_abnormal_nociception_after | 1.21665125 |
| 53 | MP0003634_abnormal_glial_cell | 1.20877947 |
| 54 | MP0004270_analgesia | 1.19632151 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.15256218 |
| 56 | MP0004233_abnormal_muscle_weight | 1.14272519 |
| 57 | MP0000383_abnormal_hair_follicle | 1.13805499 |
| 58 | MP0001984_abnormal_olfaction | 1.12209617 |
| 59 | MP0004134_abnormal_chest_morphology | 1.12189896 |
| 60 | MP0000955_abnormal_spinal_cord | 1.11789019 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.10346815 |
| 62 | MP0000751_myopathy | 1.10337046 |
| 63 | MP0001486_abnormal_startle_reflex | 1.10305598 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.09817178 |
| 65 | MP0003195_calcinosis | 1.08252681 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.07155342 |
| 67 | MP0002127_abnormal_cardiovascular_syste | 1.06381337 |
| 68 | MP0004924_abnormal_behavior | 1.06120116 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.06120116 |
| 70 | MP0002067_abnormal_sensory_capabilities | 1.03732721 |
| 71 | MP0009046_muscle_twitch | 1.02648995 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 0.99396167 |
| 73 | MP0004885_abnormal_endolymph | 0.99028127 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.98827273 |
| 75 | MP0008775_abnormal_heart_ventricle | 0.98701041 |
| 76 | MP0004043_abnormal_pH_regulation | 0.98590190 |
| 77 | MP0003122_maternal_imprinting | 0.97941354 |
| 78 | MP0004883_abnormal_blood_vessel | 0.97066924 |
| 79 | MP0001188_hyperpigmentation | 0.97058214 |
| 80 | MP0002269_muscular_atrophy | 0.96911160 |
| 81 | MP0002106_abnormal_muscle_physiology | 0.96590772 |
| 82 | MP0000428_abnormal_craniofacial_morphol | 0.96420794 |
| 83 | MP0002733_abnormal_thermal_nociception | 0.96044856 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.95983409 |
| 85 | MP0004381_abnormal_hair_follicle | 0.95240705 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 0.94400368 |
| 87 | MP0003633_abnormal_nervous_system | 0.93766299 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.93403549 |
| 89 | MP0001440_abnormal_grooming_behavior | 0.92917480 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.92835866 |
| 91 | MP0002075_abnormal_coat/hair_pigmentati | 0.90404319 |
| 92 | MP0001502_abnormal_circadian_rhythm | 0.90345242 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.89395073 |
| 94 | MP0003091_abnormal_cell_migration | 0.88911705 |
| 95 | MP0001661_extended_life_span | 0.88446982 |
| 96 | MP0005171_absent_coat_pigmentation | 0.87911153 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.87319192 |
| 98 | MP0010307_abnormal_tumor_latency | 0.87305635 |
| 99 | MP0009278_abnormal_bone_marrow | 0.86608690 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.85841529 |
| 101 | MP0006276_abnormal_autonomic_nervous | 0.85716520 |
| 102 | MP0000778_abnormal_nervous_system | 0.84333155 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.83641290 |
| 104 | MP0004085_abnormal_heartbeat | 0.82611462 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.82009144 |
| 106 | MP0003045_fibrosis | 0.81975285 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.81574558 |
| 108 | MP0001186_pigmentation_phenotype | 0.80393636 |
| 109 | MP0002184_abnormal_innervation | 0.80278537 |
| 110 | MP0001970_abnormal_pain_threshold | 0.80070795 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.80037900 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.79748818 |
| 113 | MP0002006_tumorigenesis | 0.78575387 |
| 114 | MP0002882_abnormal_neuron_morphology | 0.77549230 |
| 115 | MP0005551_abnormal_eye_electrophysiolog | 0.75711291 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.75590335 |
| 117 | MP0003631_nervous_system_phenotype | 0.74534150 |
| 118 | MP0003137_abnormal_impulse_conducting | 0.74008259 |
| 119 | MP0004142_abnormal_muscle_tone | 0.73689321 |
| 120 | MP0005253_abnormal_eye_physiology | 0.71805933 |
| 121 | MP0002272_abnormal_nervous_system | 0.70593213 |
| 122 | MP0002971_abnormal_brown_adipose | 0.68970267 |
| 123 | MP0000920_abnormal_myelination | 0.68493511 |
| 124 | MP0005670_abnormal_white_adipose | 0.68434109 |
| 125 | MP0005369_muscle_phenotype | 0.68258263 |
| 126 | MP0003632_abnormal_nervous_system | 0.66494400 |
| 127 | MP0005310_abnormal_salivary_gland | 0.65292556 |
| 128 | MP0003690_abnormal_glial_cell | 0.64515889 |
| 129 | MP0002229_neurodegeneration | 0.64399267 |
| 130 | MP0001835_abnormal_antigen_presentation | 0.63830437 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.63746341 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.61851792 |
| 133 | MP0003121_genomic_imprinting | 0.61156096 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.60501086 |
| 135 | MP0005645_abnormal_hypothalamus_physiol | 0.59235523 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.58420447 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.58118566 |
| 138 | MP0004484_altered_response_of | 0.57442569 |
| 139 | MP0003279_aneurysm | 0.56921960 |
| 140 | MP0002066_abnormal_motor_capabilities/c | 0.55997997 |
| 141 | MP0004215_abnormal_myocardial_fiber | 0.55852988 |
| 142 | MP0001501_abnormal_sleep_pattern | 0.54639428 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.54027807 |
| 144 | MP0002419_abnormal_innate_immunity | 0.53698736 |
| 145 | MP0001324_abnormal_eye_pigmentation | 0.53487425 |
| 146 | MP0008877_abnormal_DNA_methylation | 0.53381993 |
| 147 | MP0003329_amyloid_beta_deposits | 0.52862798 |
| 148 | MP0004130_abnormal_muscle_cell | 0.52198148 |
| 149 | MP0003303_peritoneal_inflammation | 0.51110458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 4.44893762 |
| 2 | Neonatal short-limb short stature (HP:0008921) | 3.98232784 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 3.64675910 |
| 4 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.64675910 |
| 5 | Aplasia of the phalanges of the hand (HP:0009802) | 3.64675910 |
| 6 | Megalencephaly (HP:0001355) | 3.16569993 |
| 7 | Heterotopia (HP:0002282) | 3.13358806 |
| 8 | Alacrima (HP:0000522) | 3.00396037 |
| 9 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 3.00250723 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.00205820 |
| 11 | Abnormality of the lumbar spine (HP:0100712) | 2.92693116 |
| 12 | Visual hallucinations (HP:0002367) | 2.82137865 |
| 13 | Difficulty running (HP:0009046) | 2.80732615 |
| 14 | Leiomyosarcoma (HP:0100243) | 2.77861316 |
| 15 | Uterine leiomyosarcoma (HP:0002891) | 2.77861316 |
| 16 | Spinal canal stenosis (HP:0003416) | 2.75170232 |
| 17 | Abnormality of incisor morphology (HP:0011063) | 2.74816639 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.69994082 |
| 19 | Subaortic stenosis (HP:0001682) | 2.69994082 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 2.66562039 |
| 21 | Xerostomia (HP:0000217) | 2.62946618 |
| 22 | Gingival bleeding (HP:0000225) | 2.54293503 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52904939 |
| 24 | Curly hair (HP:0002212) | 2.46857990 |
| 25 | T lymphocytopenia (HP:0005403) | 2.42089306 |
| 26 | Hematochezia (HP:0002573) | 2.41712117 |
| 27 | Decreased lacrimation (HP:0000633) | 2.41149022 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.38399245 |
| 29 | Thyroid carcinoma (HP:0002890) | 2.35192682 |
| 30 | Febrile seizures (HP:0002373) | 2.34393668 |
| 31 | Focal motor seizures (HP:0011153) | 2.34243938 |
| 32 | Fair hair (HP:0002286) | 2.33722185 |
| 33 | Absent speech (HP:0001344) | 2.31964428 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 2.30761826 |
| 35 | Hypoplastic ischia (HP:0003175) | 2.30712120 |
| 36 | Striae distensae (HP:0001065) | 2.29697637 |
| 37 | Vascular tortuosity (HP:0004948) | 2.28527110 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.28294879 |
| 39 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.28223242 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.25332847 |
| 41 | Abnormality of the ischium (HP:0003174) | 2.24662101 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.24462279 |
| 43 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24189642 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.23819910 |
| 45 | Recurrent corneal erosions (HP:0000495) | 2.23183394 |
| 46 | Renal cortical cysts (HP:0000803) | 2.22321979 |
| 47 | Nemaline bodies (HP:0003798) | 2.22159236 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.21538014 |
| 49 | Arterial thrombosis (HP:0004420) | 2.19929093 |
| 50 | Abnormality of the salivary glands (HP:0010286) | 2.18492339 |
| 51 | Inappropriate behavior (HP:0000719) | 2.18244293 |
| 52 | Aortic aneurysm (HP:0004942) | 2.17486931 |
| 53 | Abnormality of the right ventricle (HP:0001707) | 2.17405087 |
| 54 | Spondylolisthesis (HP:0003302) | 2.17343074 |
| 55 | Focal seizures (HP:0007359) | 2.17324323 |
| 56 | Abnormality of salivation (HP:0100755) | 2.15722694 |
| 57 | Broad-based gait (HP:0002136) | 2.14976531 |
| 58 | Adactyly (HP:0009776) | 2.13640173 |
| 59 | Absent frontal sinuses (HP:0002688) | 2.12844802 |
| 60 | Hip dysplasia (HP:0001385) | 2.12395874 |
| 61 | Cystic hygroma (HP:0000476) | 2.12143996 |
| 62 | Macroorchidism (HP:0000053) | 2.12127833 |
| 63 | Exercise-induced myalgia (HP:0003738) | 2.09433015 |
| 64 | Thickened helices (HP:0000391) | 2.09074024 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.08964795 |
| 66 | Protruding tongue (HP:0010808) | 2.08618849 |
| 67 | Muscle fiber inclusion bodies (HP:0100299) | 2.08520083 |
| 68 | Widely spaced teeth (HP:0000687) | 2.08414916 |
| 69 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08376671 |
| 70 | Termporal pattern (HP:0011008) | 2.08147266 |
| 71 | Insidious onset (HP:0003587) | 2.08147266 |
| 72 | Testicular neoplasm (HP:0010788) | 2.08062568 |
| 73 | Postural instability (HP:0002172) | 2.07078885 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.07037497 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.06888367 |
| 76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.06888367 |
| 77 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.06716566 |
| 78 | Frequent falls (HP:0002359) | 2.06479644 |
| 79 | Orchitis (HP:0100796) | 2.05722613 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.04250258 |
| 81 | Neurodegeneration (HP:0002180) | 2.03549185 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.03495592 |
| 83 | Facial diplegia (HP:0001349) | 2.03291339 |
| 84 | Disinhibition (HP:0000734) | 2.01826320 |
| 85 | Long clavicles (HP:0000890) | 2.01823416 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 2.00512151 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99924664 |
| 88 | Bladder carcinoma (HP:0002862) | 1.99859462 |
| 89 | Bladder neoplasm (HP:0009725) | 1.99859462 |
| 90 | Ocular albinism (HP:0001107) | 1.99768872 |
| 91 | Myositis (HP:0100614) | 1.99429327 |
| 92 | Mutism (HP:0002300) | 1.98812980 |
| 93 | Central scotoma (HP:0000603) | 1.98281958 |
| 94 | Menstrual irregularities (HP:0000858) | 1.98252979 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97857519 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 1.97677917 |
| 97 | Bundle branch block (HP:0011710) | 1.96511526 |
| 98 | Lower limb muscle weakness (HP:0007340) | 1.95995775 |
| 99 | Tubulointerstitial nephritis (HP:0001970) | 1.95815652 |
| 100 | Generalized hypopigmentation of hair (HP:0011358) | 1.95695842 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 1.94566993 |
| 102 | Germ cell neoplasia (HP:0100728) | 1.94520602 |
| 103 | Urethral obstruction (HP:0000796) | 1.94131957 |
| 104 | Abnormality of the calf musculature (HP:0001430) | 1.92791198 |
| 105 | Excessive salivation (HP:0003781) | 1.92110731 |
| 106 | Drooling (HP:0002307) | 1.92110731 |
| 107 | Abnormality of the costochondral junction (HP:0000919) | 1.91321050 |
| 108 | Intellectual disability, profound (HP:0002187) | 1.91095810 |
| 109 | Impaired vibratory sensation (HP:0002495) | 1.91029917 |
| 110 | Distal arthrogryposis (HP:0005684) | 1.90981411 |
| 111 | Chest pain (HP:0100749) | 1.90921329 |
| 112 | Hemiplegia (HP:0002301) | 1.89879525 |
| 113 | Truncal obesity (HP:0001956) | 1.88874507 |
| 114 | Genetic anticipation (HP:0003743) | 1.88644257 |
| 115 | Arterial tortuosity (HP:0005116) | 1.88259254 |
| 116 | Stomatitis (HP:0010280) | 1.88251027 |
| 117 | Neoplasm of the adrenal cortex (HP:0100641) | 1.87317331 |
| 118 | Depression (HP:0000716) | 1.87097594 |
| 119 | Thyroiditis (HP:0100646) | 1.85098915 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84913776 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84913776 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84913776 |
| 123 | Medial flaring of the eyebrow (HP:0010747) | 1.84800860 |
| 124 | Recurrent skin infections (HP:0001581) | 1.84328238 |
| 125 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.83628842 |
| 126 | Aqueductal stenosis (HP:0002410) | 1.83453314 |
| 127 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83383642 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.83081338 |
| 129 | Hyperlipoproteinemia (HP:0010980) | 1.82434909 |
| 130 | Neonatal death (HP:0003811) | 1.81856850 |
| 131 | Iris hypopigmentation (HP:0007730) | 1.81078911 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 1.80892845 |
| 133 | Recurrent abscess formation (HP:0002722) | 1.80315703 |
| 134 | Cerebral aneurysm (HP:0004944) | 1.79751127 |
| 135 | Coronal craniosynostosis (HP:0004440) | 1.79342723 |
| 136 | Progressive inability to walk (HP:0002505) | 1.79262295 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.78992123 |
| 138 | Keratoconjunctivitis (HP:0001096) | 1.78671841 |
| 139 | Gait imbalance (HP:0002141) | 1.78463131 |
| 140 | Atonic seizures (HP:0010819) | 1.77793132 |
| 141 | Progressive sensorineural hearing impairment (HP:0000408) | 1.77444731 |
| 142 | EMG: neuropathic changes (HP:0003445) | 1.76507104 |
| 143 | Abnormality of the antihelix (HP:0009738) | 1.75713884 |
| 144 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75518169 |
| 145 | Epileptic encephalopathy (HP:0200134) | 1.74984380 |
| 146 | Progressive cerebellar ataxia (HP:0002073) | 1.73147783 |
| 147 | Optic neuritis (HP:0100653) | 1.73098405 |
| 148 | Retrobulbar optic neuritis (HP:0100654) | 1.73098405 |
| 149 | Sudden death (HP:0001699) | 1.73044991 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.72934180 |
| 151 | Gingivitis (HP:0000230) | 1.72649251 |
| 152 | Gastrointestinal infarctions (HP:0005244) | 1.71625501 |
| 153 | Action tremor (HP:0002345) | 1.71398321 |
| 154 | Infantile muscular hypotonia (HP:0008947) | 1.70819626 |
| 155 | Partial duplication of thumb phalanx (HP:0009944) | 1.69261711 |
| 156 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68670957 |
| 157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68670957 |
| 158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68670957 |
| 159 | Albinism (HP:0001022) | 1.68606354 |
| 160 | Mixed hearing impairment (HP:0000410) | 1.68191700 |
| 161 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66729582 |
| 162 | Congenital primary aphakia (HP:0007707) | 1.66548968 |
| 163 | Syncope (HP:0001279) | 1.66212978 |
| 164 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.66184848 |
| 165 | Muscle fiber splitting (HP:0003555) | 1.66119016 |
| 166 | Inability to walk (HP:0002540) | 1.65655359 |
| 167 | Dialeptic seizures (HP:0011146) | 1.65480810 |
| 168 | Papillary thyroid carcinoma (HP:0002895) | 1.65042795 |
| 169 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64587598 |
| 170 | Apathy (HP:0000741) | 1.63827670 |
| 171 | Abnormality of macular pigmentation (HP:0008002) | 1.62485025 |
| 172 | Asymmetric septal hypertrophy (HP:0001670) | 1.60985134 |
| 173 | Conical tooth (HP:0000698) | 1.60581363 |
| 174 | Flared metaphyses (HP:0003015) | 1.60578733 |
| 175 | Diminished motivation (HP:0000745) | 1.59579700 |
| 176 | Choroideremia (HP:0001139) | 1.59400563 |
| 177 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.57975822 |
| 178 | Agitation (HP:0000713) | 1.56921873 |
| 179 | Spinal muscular atrophy (HP:0007269) | 1.56688079 |
| 180 | Papilledema (HP:0001085) | 1.56345356 |
| 181 | Diplopia (HP:0000651) | 1.55765982 |
| 182 | Abnormality of binocular vision (HP:0011514) | 1.55765982 |
| 183 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.55536916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.24280003 |
| 2 | FGFR3 | 3.81089221 |
| 3 | BUB1 | 3.39676161 |
| 4 | MARK1 | 2.70027807 |
| 5 | PRKD3 | 2.65119228 |
| 6 | OBSCN | 2.31313748 |
| 7 | NTRK3 | 2.28976635 |
| 8 | CAMK1D | 2.20564123 |
| 9 | ACVR1B | 2.13310112 |
| 10 | SGK2 | 1.96607901 |
| 11 | SGK223 | 1.90144503 |
| 12 | SGK494 | 1.90144503 |
| 13 | TAOK3 | 1.87047745 |
| 14 | SCYL2 | 1.86673582 |
| 15 | SGK3 | 1.80999078 |
| 16 | PRKCH | 1.80809938 |
| 17 | DAPK2 | 1.78169997 |
| 18 | BLK | 1.75009068 |
| 19 | FGR | 1.74473882 |
| 20 | EPHA3 | 1.74451800 |
| 21 | WNK3 | 1.70032784 |
| 22 | RIPK4 | 1.68105265 |
| 23 | PIK3CG | 1.67508283 |
| 24 | PAK6 | 1.65435450 |
| 25 | CAMK1G | 1.64917673 |
| 26 | TNIK | 1.62101029 |
| 27 | CAMKK1 | 1.61255170 |
| 28 | JAK1 | 1.57611699 |
| 29 | MAP2K7 | 1.57056944 |
| 30 | MAP3K13 | 1.54001474 |
| 31 | FGFR2 | 1.53253811 |
| 32 | SIK2 | 1.52738766 |
| 33 | MAP3K14 | 1.51284732 |
| 34 | MAP2K4 | 1.47825949 |
| 35 | PAK3 | 1.46766321 |
| 36 | MAP3K4 | 1.46376100 |
| 37 | FGFR1 | 1.43652597 |
| 38 | TEC | 1.39734220 |
| 39 | NEK6 | 1.38381540 |
| 40 | CCNB1 | 1.37905492 |
| 41 | PTK2B | 1.35196049 |
| 42 | AKT3 | 1.33049290 |
| 43 | PRPF4B | 1.32863099 |
| 44 | TXK | 1.27625267 |
| 45 | CAMKK2 | 1.22903299 |
| 46 | CDK8 | 1.21428197 |
| 47 | SGK1 | 1.19422191 |
| 48 | NTRK1 | 1.18615818 |
| 49 | MINK1 | 1.11630690 |
| 50 | MAP4K2 | 1.08306530 |
| 51 | MAP2K3 | 1.07155405 |
| 52 | PINK1 | 1.04245137 |
| 53 | STK38 | 1.04059000 |
| 54 | CDC42BPA | 1.03592158 |
| 55 | CDK5 | 1.03571331 |
| 56 | BCR | 1.02764447 |
| 57 | BTK | 1.00548888 |
| 58 | KIT | 0.99689131 |
| 59 | BRD4 | 0.99498878 |
| 60 | MAP3K9 | 0.99216016 |
| 61 | YES1 | 0.98861043 |
| 62 | BMX | 0.98606123 |
| 63 | FER | 0.97108946 |
| 64 | OXSR1 | 0.96526268 |
| 65 | NTRK2 | 0.95592152 |
| 66 | MAP3K7 | 0.95276308 |
| 67 | CSF1R | 0.93857123 |
| 68 | JAK2 | 0.93267603 |
| 69 | ALK | 0.92880377 |
| 70 | TRPM7 | 0.92661082 |
| 71 | ERBB3 | 0.92167785 |
| 72 | CAMK4 | 0.90310771 |
| 73 | TGFBR2 | 0.89932541 |
| 74 | DAPK1 | 0.88877477 |
| 75 | TNK2 | 0.88490410 |
| 76 | ZAK | 0.88421558 |
| 77 | TTN | 0.88287071 |
| 78 | RIPK1 | 0.87413089 |
| 79 | PDGFRA | 0.86484972 |
| 80 | WNK1 | 0.86220568 |
| 81 | IRAK1 | 0.85445111 |
| 82 | STK11 | 0.85092886 |
| 83 | MAPK10 | 0.84546594 |
| 84 | SYK | 0.84181893 |
| 85 | PKN2 | 0.83988338 |
| 86 | PDK1 | 0.83911418 |
| 87 | KSR1 | 0.82816597 |
| 88 | NEK9 | 0.80420616 |
| 89 | DMPK | 0.79690512 |
| 90 | TRIB3 | 0.79401498 |
| 91 | BMPR2 | 0.79226970 |
| 92 | MELK | 0.77826460 |
| 93 | MAP3K2 | 0.77735661 |
| 94 | PRKCE | 0.76279608 |
| 95 | PRKCZ | 0.76048883 |
| 96 | PRKAA1 | 0.74945715 |
| 97 | ITK | 0.74830100 |
| 98 | JAK3 | 0.73107320 |
| 99 | FES | 0.73016732 |
| 100 | NLK | 0.72846598 |
| 101 | RET | 0.72257979 |
| 102 | PRKCG | 0.71174699 |
| 103 | PLK2 | 0.71152387 |
| 104 | CSK | 0.70813887 |
| 105 | MAPK13 | 0.70093873 |
| 106 | EPHA4 | 0.69115511 |
| 107 | PDGFRB | 0.68313128 |
| 108 | DYRK1A | 0.67526703 |
| 109 | CDK12 | 0.67208196 |
| 110 | BMPR1B | 0.66733945 |
| 111 | CHUK | 0.66007827 |
| 112 | MAP3K6 | 0.64533678 |
| 113 | PHKG2 | 0.63877420 |
| 114 | PHKG1 | 0.63877420 |
| 115 | MARK3 | 0.63567188 |
| 116 | ROCK1 | 0.63404068 |
| 117 | CASK | 0.62385024 |
| 118 | LMTK2 | 0.61462065 |
| 119 | PRKAA2 | 0.60987304 |
| 120 | MAP3K5 | 0.60957236 |
| 121 | IKBKE | 0.58797239 |
| 122 | RPS6KB1 | 0.58714872 |
| 123 | LYN | 0.56792742 |
| 124 | MTOR | 0.56593112 |
| 125 | NEK2 | 0.55683699 |
| 126 | IRAK4 | 0.53910107 |
| 127 | TIE1 | 0.53621491 |
| 128 | CDK9 | 0.53044467 |
| 129 | RPS6KA3 | 0.52667453 |
| 130 | LCK | 0.52437950 |
| 131 | TRIM28 | 0.51670486 |
| 132 | EPHB1 | 0.51563206 |
| 133 | PDPK1 | 0.50882701 |
| 134 | CAMK1 | 0.49376133 |
| 135 | INSRR | 0.49248002 |
| 136 | PIK3CA | 0.48650453 |
| 137 | MARK2 | 0.48576027 |
| 138 | PRKCB | 0.48080307 |
| 139 | IGF1R | 0.47798045 |
| 140 | RPS6KA2 | 0.46933346 |
| 141 | PKN1 | 0.46830603 |
| 142 | GRK6 | 0.46786507 |
| 143 | ICK | 0.46673090 |
| 144 | TYK2 | 0.46064679 |
| 145 | NUAK1 | 0.46041961 |
| 146 | FYN | 0.46014425 |
| 147 | RAF1 | 0.45671746 |
| 148 | ERBB2 | 0.45527103 |
| 149 | MAPK9 | 0.45326601 |
| 150 | MAPK12 | 0.45188545 |
| 151 | MKNK2 | 0.45076459 |
| 152 | ADRBK1 | 0.44834296 |
| 153 | AKT2 | 0.43079918 |
| 154 | UHMK1 | 0.42313608 |
| 155 | TAOK1 | 0.41985830 |
| 156 | BRSK1 | 0.40196764 |
| 157 | PTK6 | 0.39479106 |
| 158 | HCK | 0.38830700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26519274 |
| 2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.90228287 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68241142 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 1.66450163 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65785916 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60706181 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 1.54696140 |
| 8 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.52531188 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51683890 |
| 10 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.49257743 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.47931846 |
| 12 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.44713301 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.43251824 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33996886 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31613796 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.30518181 |
| 17 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.26057102 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26011829 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.24657571 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23538652 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22232361 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22065282 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21489872 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20748881 |
| 25 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20653944 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19947653 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.19081585 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.18452061 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17831550 |
| 30 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.15086154 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12140619 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10443068 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.08909267 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07123540 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05443149 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04733980 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04498418 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04358202 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02116526 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01004666 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99395152 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99060309 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98256086 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97689936 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97564991 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.96773682 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94920255 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93707272 |
| 49 | Glioma_Homo sapiens_hsa05214 | 0.92655209 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92546153 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92108438 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91601183 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90769925 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90152496 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90060625 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.88506402 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88350726 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86421463 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85989636 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85720434 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.85527258 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85393152 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85024141 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.84150280 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82795365 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82780573 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80496199 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79769540 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79741603 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.79677961 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79588818 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78564008 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.78402192 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78394521 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.77573907 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77335430 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76806294 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.75894627 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75577383 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.75266149 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75110844 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.74510010 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74134619 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73641557 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72283346 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72276332 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71908895 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71606370 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71380062 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71163221 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70576466 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70469833 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70168700 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69937188 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69718454 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69521149 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68683202 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68361092 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68183401 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68050907 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67536230 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66812414 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66650645 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66270890 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.65730058 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65701195 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.65222306 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64212746 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63970548 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63262301 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62983876 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62699897 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61926389 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61781208 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61183338 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60577492 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60416519 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59907061 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.59818628 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59804738 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.59145513 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58918421 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58743477 |
| 124 | Melanogenesis_Homo sapiens_hsa04916 | 0.58535005 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57721919 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57560796 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57394907 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57134925 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56794583 |

